Literature DB >> 23566648

Survival and quality of life for nonagenarians after cardiac surgery.

Manuel Caceres1, Wen Cheng, Michele De Robertis, James M Mirocha, Lawrence Czer, Fardad Esmailian, Ali Khoynezhad, Danny Ramzy, Robert Kass, Alfredo Trento.   

Abstract

BACKGROUND: Reports of cardiac surgery in the elderly have focused primarily on septuagenarians and octogenarians. There are very limited data regarding risk-adjusted models in nonagenarians.
METHODS: From 1983 to 2011, patients with age 90 years or greater at the time of coronary artery bypass grafting (CABG) or valve surgery (aortic or mitral) were retrieved from a prospective institutional database. A Cox proportional hazard model was used to determine significant predictors of 5-year survival. In addition, a 12-month assessment of quality of life was conducted.
RESULTS: The CABG-only (n = 46), valve-only (n = 55), or CABG-valve (n = 53) surgery was conducted in 154 patients. Demographic characteristics were similar in all groups except for congestive heart failure, which was more prominent in the valve-only or CABG-valve groups (p < 0.0001). The 30-day mortality was 8.8%, 12.8%, and 18.9% in the CABG-only, valve-only, and CABG-valve groups, respectively, without significant difference among groups (p = 0.35). At 5-years follow-up, the Kaplan-Meier survival curves do not show a difference among groups (p = 0.62). Cox proportional hazard model for 5-year survival identified age (hazard ratio [HR] = 1.25, confidence interval [CI] 1.09 to 1.43, p = 0.001, for 1-year increase), prior surgery (HR = 2.23, CI 1.23 to 4.64, p = 0.007), and prior stroke (HR = 2.39, CI 1.25 to 3.98, p = 0.01), as significant predictors of mortality. The 12-month quality of life questionnaire revealed an improvement in 83% of the patients, whereas only 4% reported a decline in cardiac status.
CONCLUSIONS: Survival in nonagenarians is comparable after CABG or valve surgery. Redo surgery, stroke, and increasing age are significant hazards for mortality. Nonagenarians can undergo cardiac surgery with acceptable mortality and quality of life.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23566648     DOI: 10.1016/j.athoracsur.2013.02.034

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Quality of Life in Patients of Different Age Groups before and after Coronary Artery By-Pass Surgery.

Authors:  Vladan Peric; Snežana Jovanovic-Markovic; Dejan Peric; Dragisa Rasic; Tatjana Novakovic; Bogdan Dejanovic; Milorad Borzanovic
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-09-02       Impact factor: 1.520

2.  Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.

Authors:  Ajay J Kirtane; Darshan Doshi; Martin B Leon; John M Lasala; E Magnus Ohman; William W O'Neill; Adhir Shroff; Mauricio G Cohen; Igor F Palacios; Nirat Beohar; Nir Uriel; Navin K Kapur; Dimitri Karmpaliotis; William Lombardi; George D Dangas; Manish A Parikh; Gregg W Stone; Jeffrey W Moses
Journal:  Circulation       Date:  2016-08-02       Impact factor: 39.918

3.  Disability-free survival after major cardiac surgery: a population-based retrospective cohort study.

Authors:  Louise Y Sun; Anan Bader Eddeen; Thierry G Mesana
Journal:  CMAJ Open       Date:  2021-04-16

4.  Modern Cardiac Surgical Outcomes in Nonagenarians: A Multicentre Retrospective Observational Study.

Authors:  Laurence Weinberg; Dominic Walpole; Dong Kyu Lee; Michael D'Silva; Jian Wen Chan; Lachlan Fraser Miles; Bradly Carp; Adam Wells; Tuck Seng Ngun; Siven Seevanayagam; George Matalanis; Ziauddin Ansari; Rinaldo Bellomo; Michael Yii
Journal:  Front Cardiovasc Med       Date:  2022-07-14

5.  Major adverse cardiac and cerebrovascular event and patients' quality of life after endoscopic vein harvesting as compared with open vein harvest (MAQEH): a pilot study.

Authors:  Heyman Luckraz; Carly Cartwright; Kumaresan Nagarajan; Prabhjeet Kaur; Alan Nevill
Journal:  Open Heart       Date:  2018-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.